ZIMMER BIOMET HOLDINGS, INC.·4

Nov 13, 4:48 PM ET

Bruneau Aure 4

4 · ZIMMER BIOMET HOLDINGS, INC. · Filed Nov 13, 2019

Insider Transaction Report

Form 4
Period: 2019-11-11
Bruneau Aure
Group President
Transactions
  • Exercise/Conversion

    Common Stock

    2019-11-11$104.01/sh+4,718$490,7195,475 total
  • Sale

    Common Stock

    2019-11-11$141.47/sh1,613$228,199757 total
  • Sale

    Common Stock

    2019-11-11$141.17/sh2,910$410,799757 total
  • Exercise/Conversion

    Common Stock

    2019-11-11$114.44/sh+2,780$318,1433,537 total
  • Exercise/Conversion

    Employee Stock Option (right to buy)

    2019-11-113,1500 total
    Exercise: $113.83Exp: 2025-06-24Common Stock (3,150 underlying)
  • Exercise/Conversion

    Employee Stock Option (right to buy)

    2019-11-112,9102,910 total
    Exercise: $121.88Exp: 2027-03-21Common Stock (2,910 underlying)
  • Exercise/Conversion

    Common Stock

    2019-11-11$113.83/sh+3,150$358,5653,907 total
  • Sale

    Common Stock

    2019-11-11$141.24/sh4,718$666,384757 total
  • Exercise/Conversion

    Common Stock

    2019-11-11$103.25/sh+1,613$166,5422,370 total
  • Exercise/Conversion

    Common Stock

    2019-11-11$121.88/sh+2,910$354,6713,667 total
  • Sale

    Common Stock

    2019-11-11$141.14/sh2,780$392,369757 total
  • Exercise/Conversion

    Employee Stock Option (right to buy)

    2019-11-114,7181,572 total
    Exercise: $104.01Exp: 2026-03-21Common Stock (4,718 underlying)
  • Sale

    Common Stock

    2019-11-11$141.31/sh3,150$445,114757 total
  • Exercise/Conversion

    Employee Stock Option (right to buy)

    2019-11-111,6131,612 total
    Exercise: $103.25Exp: 2027-01-03Common Stock (1,613 underlying)
  • Exercise/Conversion

    Employee Stock Option (right to buy)

    2019-11-112,7808,340 total
    Exercise: $114.44Exp: 2028-03-20Common Stock (2,780 underlying)
Footnotes (10)
  • [F1]Represents the sale of 3,150 shares in multiple transactions ranging in price from $140.98 to $141.595 per share, resulting in a weighted average sale price of $141.306. The reporting person will provide, upon request by the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each price within the range.
  • [F10]2,780 options vested on March 20, 2019; and the remaining unvested options will vest in equal portions on each of March 20, 2020, March 20, 2021 and March 20, 2022.
  • [F2]Represents the sale of 4,718 shares in multiple transactions ranging in price from $141.005 to $141.64 per share, resulting in a weighted average sale price of $141.243. The reporting person will provide, upon request by the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each price within the range.
  • [F3]Represents the sale of 1,613 shares in multiple transactions ranging in price from $141.00 to $141.72 per share, resulting in a weighted average sale price of $141.475. The reporting person will provide, upon request by the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each price within the range.
  • [F4]Represents the sale of 2,910 shares in multiple transactions ranging in price from $141.065 to $141.505 per share, resulting in a weighted average sale price of $141.168. The reporting person will provide, upon request by the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each price within the range.
  • [F5]Represents the sale of 2,780 shares in multiple transactions ranging in price from $140.995 to $141.59 per share, resulting in a weighted average sale price of $141.14. The reporting person will provide, upon request by the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each price within the range.
  • [F6]One-fourth of the options vested on each of June 24, 2016, June 24, 2017, June 24, 2018 and June 24, 2019.
  • [F7]4,718 of the options vested in thirds on each of March 21, 2017, March 21, 2018 and March 21, 2019; and the remaining unvested options will vest on March 21, 2020.
  • [F8]806 options vested on January 3, 2018; 807 options vested on January 3, 2019; and the remaining unvested options will vest in equal portions on each of January 3, 2020 and January 3, 2021.
  • [F9]1,455 options vested on each of March 21, 2018 and March 21, 2019; and the remaining unvested options will vest in equal portions on each of March 21, 2020 and March 21, 2021.

Documents

1 file
  • 4
    edgar.xmlPrimary

    PRIMARY DOCUMENT